NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults
June 01, 2021 07:00 ET
|
NMD Pharma
PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Aarhus, Denmark, 1 June 2021 – NMD Pharma A/S,...
NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults
June 01, 2021 02:00 ET
|
NMD Pharma
PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Aarhus, Denmark, 1 June 2021 – NMD Pharma A/S,...
Support Immune Function and Muscle Health With Rejuvenate During Prolonged Inactivity
April 07, 2020 12:05 ET
|
Element Nutrition, Inc.: Rejuvenate
BURLINGTON, Ontario, April 07, 2020 (GLOBE NEWSWIRE) -- While people are stockpiling common immune-strengthening supplements like vitamins C, D and zinc, one group of overlooked nutrients that are...
Seven Summer Strengthening Secrets That Can Rejuvenate Muscle Health
June 11, 2019 08:25 ET
|
Element Nutrition, Inc.: Rejuvenate
BURLINGTON, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- As we shed more clothes during the summer, one of the body’s most valuable assets is exposed: muscle tone. Those who have more of it not only...
Rejuvenate Reverses Muscle Loss From Aging Without Exercise
February 18, 2019 08:00 ET
|
Element Nutrition, Inc.: Rejuvenate
BURLINGTON, Ontario, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Middle-aged adults are failing in the fight against frailty. Health officials say age-related muscle and strength loss, or sarcopenia, will...
AstaMed MYO™ Launches New Nationwide Distribution Partnership with Kelley-Ross Pharmacy Group
December 06, 2018 14:15 ET
|
AstaMed
Seattle, Dec. 06, 2018 (GLOBE NEWSWIRE) -- AstaMed, the Bellevue-based biotech pioneer with a new medical protocol currently available for the management of sarcopenia, announced a new nationwide...
Study Finds Seniors with Muscle Loss Due to Sarcopenia Improve with New Prescription Protocol
October 01, 2018 13:55 ET
|
AstaMed
Seattle, WA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- AstaMed, a pioneer in the field of natural sarcopenia treatment options, announced the results of the randomized, double-blind placebo-controlled study...
MYOS Corporation Announces 1-for-50 Reverse Stock Split Following Five Consecutive Quarters of Market Expansion and Revenue Growth
February 10, 2014 07:30 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Feb 10, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Begins Groundbreaking Clinical Study on Muscle Health; Research Designed to Validate the Strengths of MYO-T12
September 20, 2012 08:29 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Sep 20, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...